Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Single-Arm, Multicenter, Prospective, Post-Market 6 Months Follow-Up Clinical Investigation to Evaluate the Safety and Effectiveness of the Blueprint Mixed Reality HOLOBLUEPRINT™ (HOLOBLUEPRINT™).

NCT06080412 is registered in ClinicalTrials.gov with Stryker Trauma and Extremities as lead sponsor.

NCT NCT06080412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06080412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Single-Arm, Multicenter, Prospective, Post-Market 6 Months Follow-Up Clinical Investigation to Evaluate the Safety and Effectiveness of the Blueprint Mixed Reality HOLOBLUEPRINT™ (HOLOBLUEPRINT™).
Lead sponsor
Stryker Trauma and Extremities
Phase
Observational
Overall status
Completed
Start date
February 8, 2024
Completion date
May 7, 2025
Enrollment
44 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis shoulder, arthritis, degenerative, cuff rotator full thickness tear, cuff tear arthropathy, orthopedic disorder